In 2025, Ireland's GDP reportedly surged by 12.3%, a figure that has raised eyebrows among economists. This spike in economic performance appears to be largely driven by strategic actions taken by pharmaceutical multinationals.
In March 2025 alone, these companies front-loaded €25.4 billion worth of exports to the United States, likely in response to impending tariffs introduced by the Trump administration. This move has led to questions about the sustainability of such growth.
Looking ahead, the first quarter of 2026 is already showing signs of contraction, suggesting that the earlier economic boom may have been more of a temporary phenomenon than a lasting trend.